Open-Label Access to ATH434 for Patients Who Completed Study ATH434-201 in France
Clinical trial NCT07729852 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07729852
- Sponsor
- Alterity Therapeutics
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2029-07-01
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.